Market Place
The FDA-inspected, USA-based Peptide Manufacturer with the Largest Worldwide Capacity. 
X
Please Wait
Applying Filters...
01 Ambiopharm, Inc. (1)
01 Glatiramer (1)
01 U.S.A (1)
54
PharmaCompass offers a list of Glatiramer API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glatiramer manufacturer or Glatiramer supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glatiramer manufacturer or Glatiramer supplier.
PharmaCompass also assists you with knowing the Glatiramer API Price utilized in the formulation of products. Glatiramer API Price is not always fixed or binding as the Glatiramer Price is obtained through a variety of data sources. The Glatiramer Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Synthetic Peptide Copolymer I manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Synthetic Peptide Copolymer I, including repackagers and relabelers. The FDA regulates Synthetic Peptide Copolymer I manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Synthetic Peptide Copolymer I API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Synthetic Peptide Copolymer I manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Synthetic Peptide Copolymer I supplier is an individual or a company that provides Synthetic Peptide Copolymer I active pharmaceutical ingredient (API) or Synthetic Peptide Copolymer I finished formulations upon request. The Synthetic Peptide Copolymer I suppliers may include Synthetic Peptide Copolymer I API manufacturers, exporters, distributors and traders.
click here to find a list of Synthetic Peptide Copolymer I suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Synthetic Peptide Copolymer I as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Synthetic Peptide Copolymer I API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Synthetic Peptide Copolymer I as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Synthetic Peptide Copolymer I and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Synthetic Peptide Copolymer I NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Synthetic Peptide Copolymer I suppliers with NDC on PharmaCompass.
We have 1 companies offering Synthetic Peptide Copolymer I
Get in contact with the supplier of your choice:
